| Title : (68)Ga-Fibroblast Activation Protein Inhibitor PET\/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy - Lanzafame_2024_J.Nucl.Med_65_880 |
| Author(s) : Lanzafame H , Mavroeidi IA , Pabst KM , Desaulniers M , Ingenwerth M , Hirmas N , Kessler L , Nader M , Bartel T , Leyser S , Barbato F , Schuler M , Bauer S , Siveke JT , Herrmann K , Hamacher R , Fendler WP |
| Ref : J Nucl Med , 65 :880 , 2024 |
| Abstract : |
| PubMedSearch : Lanzafame_2024_J.Nucl.Med_65_880 |
| PubMedID: 38724279 |
| Title : (68)Ga-Fibroblast Activation Protein Inhibitor PET\/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy - Lanzafame_2024_J.Nucl.Med_65_880 |
| Author(s) : Lanzafame H , Mavroeidi IA , Pabst KM , Desaulniers M , Ingenwerth M , Hirmas N , Kessler L , Nader M , Bartel T , Leyser S , Barbato F , Schuler M , Bauer S , Siveke JT , Herrmann K , Hamacher R , Fendler WP |
| Ref : J Nucl Med , 65 :880 , 2024 |
| Abstract : |
| PubMedSearch : Lanzafame_2024_J.Nucl.Med_65_880 |
| PubMedID: 38724279 |
| Title : (68)Ga-Fibroblast Activation Protein Inhibitor PET\/CT Improves Detection of Intermediate and Low-Grade Sarcomas and Identifies Candidates for Radiopharmaceutical Therapy - Lanzafame_2024_J.Nucl.Med_65_880 |
| Author(s) : Lanzafame H , Mavroeidi IA , Pabst KM , Desaulniers M , Ingenwerth M , Hirmas N , Kessler L , Nader M , Bartel T , Leyser S , Barbato F , Schuler M , Bauer S , Siveke JT , Herrmann K , Hamacher R , Fendler WP |
| Ref : J Nucl Med , 65 :880 , 2024 |
| Abstract : |
| PubMedSearch : Lanzafame_2024_J.Nucl.Med_65_880 |
| PubMedID: 38724279 |